HEPION PHARMACEUTICALS, INC.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Mar 2022 | $9.2M | $95.9M | $79.2M |
| Jun 2022 | $16.2M | $83.6M | $71.7M |
| Sep 2022 | $10.4M | $69.7M | $59.1M |
| Dec 2022 | $10.4M | $60.2M | $51.2M |
| Mar 2023 | $12.3M | $49.5M | $43.0M |
| Jun 2023 | $10.1M | $36.5M | $30.5M |
| Sep 2023 | $8.8M | $25.0M | $19.3M |
| Dec 2023 | $10.8M | $18.1M | $14.8M |
| Mar 2024 | $8.5M | $16.0M | $13.1M |
| Jun 2024 | $2.4M | $6.0M | $2.1M |
| Sep 2024 | $4.1M | $3.7M | $1.5M |
| Dec 2024 | $3.5M | $1.6M | $406.4K |
| Mar 2025 | $2.4M | $6.3M | $4.6M |
| Jun 2025 | $708.5K | $4.5M | $2.9M |
| Sep 2025 | $415.8K | $3.7M | $2.3M |
| Dec 2025 | $402.4K | $3.1M | $1.8M |
| Mar 2026 | $848.7K | $2.7M | $2.6M |
| Jun 2026 | $648.9K | $1.9M | $1.6M |